CDH1 and cancer: Overall, the evidence is lacking to support routine enhanced cancer screening, especially colorectal, in CDH1 mutation families [8,19], unless there is a family history of first- and second-degree relatives with a colorectal histopathology showing a mucinous component and/or signet-ring cells [6].